Skip to content

Validation and Feasibility of Noninvasive Oxygen Delivery Index Monitoring in Cardiac Surgery Patients

Validation and Feasibility of Noninvasive Oxygen Delivery Index Monitoring in Cardiac Surgery Patients

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07573306
Enrollment
150
Registered
2026-05-07
Start date
2026-10-15
Completion date
2027-08-01
Last updated
2026-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Surgery

Brief summary

This study will establish the feasibility and preliminary validity of real-time oxygen delivery index (DO₂i) monitoring using noninvasive hemoglobin (SpHb, Masimo) and minimally invasive cardiac output (FloTrac, Edwards) in cardiac surgery patients.

Interventions

DEVICESpHb monitor

The SpHb monitor is an FDA approved device being used according to its approved indications. No additional invasive procedures, blood draws, or interventions are performed for research purposes.

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults ≥ 18 years undergoing cardiac surgery * Placement of pulmonary artery catheter with continuous cardiac output (CCO) as part of routine clinical care * Placement of arterial line with FloTrac as part of routine clinical care * Availability of ≥ 3 arterial blood gas samples at specified timepoints

Exclusion criteria

* Mechanical circulatory support planned or in use (IABP, Impella, ECMO) * Patients without BOTH pulmonary artery catheter with CCO and arterial line with FloTrac * Patients who are Research Opt-Out

Design outcomes

Primary

MeasureTime frameDescription
Agreement Between SpHb-Based and Pulmonary Artery Catheter Oxygen Delivery IndexThree intraoperative timepoints during cardiac surgery: baseline, post-heparin, and post-protamineBias and 95% limits of agreement between monitor-derived DO₂i (calculated from continuous SpHb and FloTrac cardiac index) and pulmonary artery catheter DO₂i (calculated from arterial blood gas hemoglobin and Swan-Ganz cardiac index), analyzed using Bland-Altman method with mixed-effects modeling to account for repeated measures. Agreement is considered acceptable if percentage error is \<30%.

Secondary

MeasureTime frameDescription
Directional Agreement for Changes in Oxygen Delivery IndexChanges between consecutive intraoperative timepoints (baseline to post-heparin, post- heparin to post-protamine) during cardiac surgeryFour-quadrant concordance rate (with 15% exclusion zone) for directional changes in DO₂i between consecutive timepoints. Concordance is defined as agreement in direction of change (increase vs decrease) between monitor-derived and gold-standard DO₂i measurements. Scores range from 0- 100%, with higher percentages indicating better directional agreement.
Correlation Between Oxygen Delivery Index and Arterial LactateThree intraoperative timepoints during cardiac surgery: baseline, post-heparin, and post- protaminePearson or Spearman correlation coefficient between DO₂i (both monitor-derived and gold- standard) and simultaneously measured arterial lactate concentration. Correlation coefficients range from -1 to +1, with negative values indicating inverse relationship between DO₂i and lactate.
Agreement Between FloTrac and Swan-Ganz Cardiac IndexThree intraoperative timepoints during cardiac surgery: baseline, post-heparin, and post- protaminePercentage error between FloTrac arterial pressure-based cardiac index and Swan-Ganz thermodilution continuous cardiac index. Percentage error is calculated as (1.96 × SD of differences) / mean cardiac index × 100%. Agreement is considered acceptable if percentage error is \<30%.
Impact of Baseline SpHb Calibration on AgreementThree intraoperative timepoints during cardiac surgery: baseline, post-heparin, and post- protamineComparison of limits of agreement before and after in vivo SpHb calibration (baseline- adjusted SpHb using first arterial blood gas hemoglobin value as reference). Measured as change in bias and 95% limits of agreement between uncalibrated and baseline-calibrated SpHb-based DO₂i compared to gold standard.
SpHb Signal Usability RateThree intraoperative timepoints during cardiac surgery: baseline, post-heparin, and post- protaminePercentage of planned timepoints with valid SpHb signal defined by perfusion index (PI) ≥ 0.5. Scores range from 0-100%, with 100% indicating valid signal at all timepoints.
Perfusion Index Threshold for Acceptable SpHb AccuracyThree intraoperative timepoints during cardiac surgery: baseline, post-heparin, and post- protamineMinimum perfusion index value associated with acceptable SpHb accuracy, defined as SpHb bias within ±1 g/dL of arterial blood gas hemoglobin. Perfusion index values range from 0-20%, with higher values indicating better peripheral perfusion.

Countries

United States

Contacts

CONTACTSherilyn Landree
landr184@umn.edu(612) 282-3705
PRINCIPAL_INVESTIGATORBenjamin Gorbaty, MD

University of Minnesota

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 19, 2026